Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MDS”

2,741 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,741 results

Not applicableStudy completedNCT03575767
What this trial is testing

Characteristics and Dynamics of TCR Repertoire in Patients With Hematological Malignancies After Allo-HSCT

Who this might be right for
Hematologic NeoplasmsHematopoietic Stem Cell TransplantationGraft Vs Host Disease+1 more
Affiliated Hospital to Academy of Military Medical Sciences 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07283900
What this trial is testing

Ascorbate in Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndromes
Prajwal Dhakal 38
Testing effectiveness (Phase 2)Study completedNCT01497145
What this trial is testing

A Clinical Study of KRN321 in Adult Subjects With Myelodysplastic Syndrome

Who this might be right for
MDS
Kyowa Kirin Co., Ltd. 45
Early research (Phase 1)Study completedNCT01757639
What this trial is testing

Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome+3 more
National Cancer Institute (NCI) 42
Early research (Phase 1)Study completedNCT00807677
What this trial is testing

Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+9 more
Millennium Pharmaceuticals, Inc. 31
Testing effectiveness (Phase 2)UnknownNCT00242515
What this trial is testing

T-cell Depleted Donor Lymphocyte Infusion (DLI)for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
National University Hospital, Singapore 16
Large-scale testing (Phase 3)Study completedNCT00412360
What this trial is testing

Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+2 more
Medical College of Wisconsin 224
Large-scale testing (Phase 3)Active Not RecruitingNCT04173533
What this trial is testing

Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCT

Who this might be right for
Acute Myeloid LeukemiaMyelodysplasia
University of Birmingham 326
Testing effectiveness (Phase 2)Looking for participantsNCT03850418
What this trial is testing

Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant

Who this might be right for
Myeloid Malignancy
Henry Ford Health System 43
Large-scale testing (Phase 3)Study completedNCT00422890
What this trial is testing

Treatment of Imminent Haematological Relapse in Patients With AML and MDS Following Allogeneic Stem Cell Transplantation With 5-azacitidine (Vidaza®)

Who this might be right for
Myeloid LeukemiaMyelodysplastic Syndrome
Technische Universität Dresden 10
Testing effectiveness (Phase 2)Study completedNCT01491958
What this trial is testing

Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaMyelodysplastic Syndrome
Ohio State University Comprehensive Cancer Center 40
Large-scale testing (Phase 3)Looking for participantsNCT06499285
What this trial is testing

Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Who this might be right for
Myelodysplastic Syndromes
Takeda 225
Testing effectiveness (Phase 2)Active Not RecruitingNCT04668885
What this trial is testing

CPX-351 as a Novel Approach for the Treatment of Older Patients With AML and MDS

Who this might be right for
Refractory Acute Myeloid LeukemiaRelapsed Acute Myelomonocytic LeukemiaMyelodysplastic Syndromes
Case Comprehensive Cancer Center 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT06001385
What this trial is testing

HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Leukemia+8 more
Center for International Blood and Marrow Transplant Research 313
Testing effectiveness (Phase 2)Study completedNCT00723099
What this trial is testing

Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+23 more
Fred Hutchinson Cancer Center 73
Early research (Phase 1)Study completedNCT00498316
What this trial is testing

Cord Blood Expansion on Mesenchymal Stem Cells

Who this might be right for
Myelodysplastic SyndromeLeukemia
M.D. Anderson Cancer Center 98
Not applicableStudy completedNCT03894852
What this trial is testing

SRSF2 Gene Mutation in Patients With t-MDS/AML

Who this might be right for
Therapy Related Myelodysplastic Syndrome and Therapy Related Acute Myeloid Leukemia
Zeinab Albadry Mohammed Zahran 139
Very early researchStudy completedNCT02181478
What this trial is testing

Intra-Osseous Co-Transplant of UCB and hMSC

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaMyelodysplastic Syndromes+9 more
Case Comprehensive Cancer Center 6
Early research (Phase 1)Ended earlyNCT02641002
What this trial is testing

CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Celgene 28
Not applicableLooking for participantsNCT03680677
What this trial is testing

Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies

Who this might be right for
Leukemia, AcuteMDS
Abramson Cancer Center at Penn Medicine 20
Load More Results